Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: J Community Support Oncol. 2015 Mar;13(3):113–116. doi: 10.12788/jcso.0117

TABLE 2.

Patients who received chemotherapy initiations in which primary G-CSF prophylaxis is indicated by guidelines (736 chemotherapy initiations).

Primary prophylaxis indicated
Primary prophylaxis not indicated
High-risk regimen (n = 46 ) Intermediate-risk regimen + at least 1 risk factor (n = 143) Intermediate-risk regimen + no risk factors (n = 61) Low-risk regimen (n = 486)
Received prophylaxis, n (%) 41 (89.1) 84 (58.7) 16 (26.2) 94 (19.3)
No prophylaxis, n (%) 5 (10.8) 59 (41.3) 45 (73.8) 392 (80.7)
Guideline adherence, %
    Each group 66a 80b
    Total 75.6
a

Appropriately received primary prophylaxis.

b

Appropriately did not receive primary prophylaxis.